Chongqing Benji Biotechnology Co., Ltd. – FDA Inspection, Apr 4, 2024

Record Details

This FDA Inspection record concerns Chongqing Benji Biotechnology Co., Ltd., with an inspection on April 4, 2024, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Chongqing Benji Biotechnology Co., Ltd.
Inspection Date: April 4, 2024
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Gavin T. Cua (Company Rep)

View Company Profile

ID · 35cdace2-78dd-40a6-8b8f-0562793f7930

Inspection Facts

Inspection number: 1236012
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Chongqing Benji Biotechnology Co., Ltd.

FDA Inspection

Chongqing Benji Biotechnology Co., Ltd.April 4, 2024

Chongqing Benji Biotechnology Co., Ltd. – FDA Inspection, Apr 4, 2024

Record Details

This FDA Inspection record concerns Chongqing Benji Biotechnology Co., Ltd., with an inspection on April 4, 2024, issued by the Office of Inspections and Investigations, covering human drugs.